2004
Results Demonstrate the Benefit of An Everolimus Eluting Coronary Stent with Durable Polymer; Investor Briefing Scheduled for 8:00 a.m. ET Tomorrow Indianapolis, Ind., and Washington, D.C. -...
Lifesaving Benefits of Implantable Defibrillators Supported by Multiple Clinical Trials Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today applauds the proposed...
Goal of Study Is To Help Physicians Recognize Patients At Risk of Unexpected Heart Attack Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced plans to conduct...
Highly Deliverable New Stent Broadens Guidant''s Market-Leading Metallic Stent Portfolio Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and...
International Trial Will Study Unnecessary Pacing in Heart Failure Patients Indianapolis, Ind. And St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that it has completed...
Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company''s...
National Registry Will Now Focus on Patient Identification and Treatment Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:GDT) today announced that its ADVANCENTSM national...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today commended the Centers for Medicare & Medicaid Services (CMS) for its intent to expand coverage of carotid artery...
Federal Circuit Court of Appeals Returns the Case to Lower Court to Determine Infringement and Damages Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won its appeal...
New Carotid Stent System Offers Minimally Invasive Alternative to Open Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced a collaboration...
Company to Reiterate Third Quarter and Full-Year Guidance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call today, Thursday, , at...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its regularly scheduled mid-quarter conference call to provide an update on the...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Advanced Leads and Lead Delivery System Further Strengthen Company''s Heart Failure Portfolio Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
U.S. Food and Drug Administration Advisory Committee Approval Based on Data from Company''s Landmark COMPANION Heart Failure Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation...
New Rapid-Exchange Dilatation Catheter Provides Foundation for Successful Interventional Procedures Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the...
Sales led by strong growth in worldwide implantable defibrillators Worldwide implantable defibrillator revenue of $456 million, up 21 percent Worldwide pacemaker revenue of $183 million, up 7 percent
Innovative System Combines Treatments for Heart Failure, Atrial Arrhythmias and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
INDIANAPOLIS-Guidant Corporation (NYSE: GDT) will conduct a live webcast of its second quarter 2004 earnings conference call on Thursday, July 22 at 11:00 a.m. EDT. The company will issue a press...
Company Makes Staged Equity Investment in Miravant Medical Technologies Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced an agreement with Miravant...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced conference call today, , at 4:30 PM EDT. On the call, the company will provide an update on its lead drug...
Webcast Scheduled for July 1 at 4:30 PM EDT Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its previously announced conference call on Thursday, July 1,...
Guidant Seeks to Expand User Labeling, Including Indications, for Cardiac Resynchronization Therapy Defibrillators Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today...